GG
CLX icon

Gleason Group’s Clorox CLX Stock Holding History

Gleason Group’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Sell
302
-151
-33% -$14.5K ﹤0.01% 163
2026
Q1 		$46.9K Buy
453
+158
+54% +$17.9K ﹤0.01% 124
2025
Q4 		$29.7K Sell
295
-266
-47% -$28.9K ﹤0.01% 137
2025
Q3 		$69.1K Buy
561
+6
+1% +$745 0.01% 99
2025
Q2 		$66.6K Buy
555
+5
+0.9% +$667 0.01% 101
2025
Q1 		$81K Buy
550
+5
+0.9% +$764 0.01% 93
2024
Q4 		$88.6K Buy
545
+4
+0.7% +$654 0.02% 91
2024
Q3 		$88.2K Buy
541
+4
+0.7% +$593 0.02% 96
2024
Q2 		$73.3K Buy
537
+4
+0.8% +$555 0.01% 102
2024
Q1 		$81.6K Buy
533
+4
+0.8% +$597 0.02% 94
2023
Q4 		$75.4K Buy
529
+5
+1% +$667 0.02% 97
2023
Q3 		$68.6K Buy
524
+4
+0.8% +$608 0.02% 103
2023
Q2 		$82.7K Buy
520
+4
+0.8% +$645 0.02% 95
2023
Q1 		$81.7K Buy
516
+4
+0.8% +$600 0.02% 93
2022
Q4 		$71.9K Buy
512
+5
+1% +$710 0.02% 98
2022
Q3 		$65K Buy
507
+4
+0.8% +$577 0.02% 99
2022
Q2 		$71K Buy
503
+3
+0.6% +$429 0.02% 98
2022
Q1 		$70K Buy
500
+4
+0.8% +$613 0.02% 103
2021
Q4 		$87K Buy
496
+4
+0.8% +$667 0.03% 88
2021
Q3 		$82K Buy
492
+3
+0.6% +$517 0.03% 93
2021
Q2 		$88K Buy
489
+3
+0.6% +$548 0.03% 85
2021
Q1 		$94K Buy
486
+3
+0.6% +$577 0.04% 81
2020
Q4 		$98K Buy
483
+3
+0.6% +$621 0.05% 78
2020
Q3 		$101K Buy
480
+2
+0.4% +$445 0.06% 70
2020
Q2 		$105K Buy
478
+2
+0.4% +$400 0.07% 68
2020
Q1 		$82K Buy
476
+3
+0.6% +$496 0.06% 67
2019
Q4 		$73K Buy
+473
New +$70.7K 0.04% 80

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Gleason Group's CLX Position: Q2 2026 in Review

Gleason Group reduced its Clorox (CLX) stake by 33% in Q2 2026, selling an estimated $14.5K and leaving 302 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #163.

Gleason Group first reported a position in CLX in Q4 2019 and has held it in 27 quarters since. The position peaked at $105K in Q2 2020. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Gleason Group held 302 shares of Clorox worth $28.8K as of Q2 2026.
  • Gleason Group sold 151 Clorox shares in Q2 2026, an estimated $14.5K.
  • Clorox made up ﹤0.01% of Gleason Group's portfolio in Q2 2026, its #163 holding.
  • Gleason Group first reported a position in Clorox in Q4 2019 and has held it in 27 quarters since.
  • Gleason Group's Clorox position peaked at $105K in Q2 2020.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.